FDA Approves Pill Form of Popular Weight Loss Drug Wegovy
In a significant development in the fight against obesity, the U.S. Food and Drug Administration has approved a pill form of Wegovy, Novo Nordisk’s widely used weight-loss medication. The newly approved pill contains 25 milligrams of semaglutide — the same active ingredient found in injectable Wegovy and the diabetes drug Ozempic.













